MARCOS DANILLO PEIXOTO OLIVEIRA
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
8 resultados
Resultados de Busca
Agora exibindo 1 - 8 de 8
- Type 4 Dual Left Anterior Descending Artery: A Very Rare Coronary Anomaly Circulation(2015) OLIVEIRA, Marcos Danillo Peixoto; MELO, Pedro H. M. Craveiro de; ESTEVES FILHO, Antonio; KAJITA, Luiz J.; RIBEIRO, Expedito E.; LEMOS, Pedro AlvesCoronary artery anomalies are congenital changes in their origin, course, and/or structure. They are the second most frequent cause of sudden death in young athletes. Dual LAD artery is a rare coronary anomaly. We present the case of a 44-year-old man with recent onset exertional angina and documented ischemia whose coronary angiogramand computed tomography (CT) showed type 4 dual LAD artery, the rarest and most interesting variant.
- Direct communication between the left circumflex and the right coronary arteries: a very rare coronary anomaly circulation(2016) OLIVEIRA, Marcos Danillo Peixoto; CAVALCANTI, Rafael R. Cesar; KAJITA, Alexandre H.; MIRANDA, Thais; KAJITA, Luiz J.; HORTA, Pedro E.; RIBEIRO, Expedito E.; LEMOS, Pedro AlvesCoronary artery anomalies (CAA) are congenital changes in their origin, course, and/or structure. Intercoronary communication (ICC) is a very rare subset with uni-or bidirectional blood flow between two or more coronary arteries. We present the case of a 58-year-old man with an acute coronary syndrome whose coronary angiography incidentally showed a surprising and very rare communication between the right coronary and left circumflex arteries.
- Giant and Calcified Post-Infarction True Left Ventricular Aneurysm: What to Do?(2016) KAJITA, Alexandre Hideo; OLIVEIRA, Marcos Danillo Peixoto; MENEZES, Fernando Reis; FRANKEN, Marcelo; BARACIOLLI, Luciano Moreira; NICOLAU, Jose Carlos
- Left Main Compression by a Giant Aneurysm of the Left Sinus of Valsalva: An Extremely Rare Reason for Myocardial Infarction and Cardiogenic Shock(2015) FAILLACE, Bruno L. R.; GALON, Micheli Z.; OLIVEIRA, Marcos Danillo P.; PRADO JR., Guy F. A.; TRUFFA, Adriano A. M.; RIBEIRO, Expedito E.; LEMOS, Pedro A.Aneurysms of the sinus of Valsalva are very rare and mostly located in the right coronary sinus. They might course with dyspnea, fatigue, and acute coronary syndromes. We present herein an extremely rare case report of a 61-year-old woman diagnosed with external left main coronary compression by a giant aneurysm of the left sinus of Valsalva, which was successfully managed with percutaneous coronary intervention.
- Superdominant Right Coronary Artery with Absence of Left Circumflex and Anomalous Origin of the Left Anterior Descending Coronary from the Right Sinus: An Unheard Coronary Anomaly Circulation(2015) OLIVEIRA, Marcos Danillo Peixoto; FAZZIO, Fernando Roberto de; MARIANI JUNIOR, Jose; CAMPOS, Carlos M.; KAJITA, Luiz Junya; RIBEIRO, Expedito E.; LEMOS, Pedro AlvesCoronary artery anomalies are congenital changes in their origin, course, and/or structure. Most of them are discovered as incidental findings during coronary angiographic studies or at autopsies. We present herein the case of a 70-year-old man with symptomatic severe aortic valvar stenosis whose preoperative coronary angiogram revealed a so far unreported coronary anomaly circulation pattern.
- Left Atrial Myxoma Hypervascularized from the Right Coronary Artery: An Interesting Cath Lab Finding(2016) OLIVEIRA, Marcos Danillo Peixoto; TAMAZATO, Adriano Ossuna; FAZZIO, Fernando Roberto de; KAJITA, Luiz J.; RIBEIRO, Expedito E.; LEMOS, Pedro AlvesPrimary cardiac tumors are rare and approximately half of them are atrial myxomas. They rarely remain asymptomatic, especially if large. The imaging of a myxoma by contrast dye during coronary angiography is an infrequent sign, which clarifies the vascular supply of the tumor. We report herein an interesting and rare case of a left atrial myxoma hypervascularized from the right coronary artery.
- Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial(2015) OLIVEIRA, Marcos Danillo Peixoto; RIBEIRO, Expedito E.; CAMPOS, Carlos M.; RIBEIRO, Henrique B.; FAILLACE, Bruno L. R.; LOPES, Augusto C.; ESPER, Rodrigo B.; MEIRELLES, George X.; PERIN, Marco A.; ABIZAID, Alexandre; LEMOS, Pedro A.Background: The Inspiron (TM) sirolimus-eluting stent (SES) is a low-dose, ultra-thin-strut cobalt-chromium stent abluminally coated with biodegradable polymers (BP). Previous results from the INSPIRON-I trial, a first-in-man study, have proven the efficacy of the novel stent in reducing neointimal proliferation. The present report aims at evaluating the long-term clinical outcomes of patients enrolled into the INSPIRON-I trial (Clinical Trials Gov. identifier: NCT01093391). Methods: A total of 57 patients (60 lesions) were randomly allocated in a 2: 1 ratio to treatment with the Inspiron (TM) SES vs. its equivalent Cronus (TM) bare metal stent (BMS, both by Scitech Medical (TM), Aparecida de Goiania, Goias, Brazil), in four tertiary centers. The primary endpoint of the present analysis was the occurrence of major adverse cardiac events (MACE) [death, myocardial infarction (MI), target vessel revascularization (TVR) and/or target lesion revascularization (TLR)] at 4 years. Results: Baseline clinical and angiographic characteristics of both groups were similar. After 4 years, the primary endpoint occurred in 7.9% vs. 23.5% of patients in Inspiron and control groups respectively (P=0.11). The rate of death/MI was similar between the groups, but there was a significant decrease in the risk of repeat revascularization in the Inspiron group compared to the control arm TLR (0.0% vs. 23.5% respectively, P= 0.02). There were no stent thromboses in the study population. Conclusions: The novel Inspiron (TM) SES showed a sustained safe and effective clinical profile after 4-year of follow-up, with very low adverse events and null stent thrombosis (ST) occurrence.
- Potential of transcatheter aortic valve replacement to improve post-procedure renal function(2017) FAILLACE, Bruno L. R.; RIBEIRO, Henrique B.; CAMPOS, Carlos M.; TRUFFA, Adriano A. M.; BERNARDI, Fernando L.; OLIVEIRA, Marcos D. P.; MARIANI JR., Jose; MARCHINI, Julio F.; TARASOUTCHI, Flavio; LEMOS, Pedro A.Background: Baseline comorbidities including renal dysfunction are frequently found in patients treated with transcatheter aortic valve replacement (TAVR) and may increase the risks of acute kidney injury (AKI), although some of them may actually improve renal function. We aimed to evaluate the potential of TAVR to acutely improve post-procedure renal function. Methods: This is a prospective single-center registry of consecutive patients with severe symptomatic aortic stenosis treated by transfemoral TAVR. Creatinine levels were determined at baseline and daily until hospital discharge. AKI was defined according to VARC-2 criteria. Patients who had improvement of creatinine levels >25% were classified as having TAVR induced renal function improvement (TIRFI). Results: A total of 69 patients undergoing TAVR were included, with a mean age of 83.0 +/- 7.4 years, being 24.6% diabetics, with a median STS score of 9.2 (5.1-21.6). Using the VARC-2 criteria, the majority of patients (64.6%) did not have renal impairment, while AKI was detected in 35.4% of the patients. Importantly, in those with prior severe renal dysfunction (clearance <30 mL/min/1.73 m(2)) or diabetes, AKI reached up to 50% and 56.3% of the patients, respectively. Conversely, acute kidney recovery (TIRFI) occurred in 12 patients (18.5%) being >50% in 1 patient (1.5%), and at hospital discharge the majority of the patients (88.6%) left the hospital in their original or better renal function categories. Conclusion: Despite multiple comorbidities in a selected TAVR-population and the use of contrast media, TAVR did not impair renal function in a majority of patients, with a significant proportion of them rather having acute renal function improvement.